Endocannabinoid System: A Multi-Facet Therapeutic Target.

Key Findings:  Several diseases like emesis, pain, inflammation, multiple sclerosis, anorexia, epilepsy, glaucoma, schizophrenia, cardiovascular disorders, cancer, obesity, metabolic syndrome related diseases, Parkinson's disease, Huntington's Disease, Alzheimer's Disease and Tourette's Syndrome could possibly be treated by drugs modulating endocannabinoid system.

Type of Study:  Meta-analysis

Study Result:  Positive

Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), SR-x Synthetic Cannabinoids, Cannabinoid (unspecified), Synthetic Cannabinoid (unspecified), Pharma THC, Pharma THC:CBD

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype I, Chemotype II

Form of Administration:  Not Applicable

Study Location(s):  India

Year of Pub:  2016

Link to study